Free Content Serum antibodies to HIV-1 are produced post-measles virus infection: evidence for cross-reactivity with HLA

Authors: Baskar1; Collins1; Dorsey-Cooper1; Pyle1; Nagel1; Dwyer2; Dunston3; Johnson4; Kendig1; Israel2; Nalin5; Adler1

Source: Clinical & Experimental Immunology, Volume 111, Number 2, February 1998 , pp. 251-256(6)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Convalescent sera obtained from patients who were recently recovered from an acute measles virus infection were tested for the presence of anti-HIV-1 antibodies by Western blot analysis. While 16% (17/104) of control sera displayed reactive bands to a variety of HIV proteins, 62% (45/73) of convalescent sera demonstrated immunoreactive bands corresponding to HIV-1 Pol and Gag, but not Env antigens. This cross-reactivity appears to be the result of an active measles infection. No HIV-1 immunoblot reactivity (0/10) was observed in sera obtained from young adults several weeks after a combined measles, mumps, and rubella (MMR) vaccination. Interestingly, examination of anti-HLA typing sera specific for either class I and class II molecules revealed that 46% (19/41) of these sera contained cross-reactive antibodies to HIV-1 proteins. Absorption of measles sera with mixed lymphocyte reaction (MLR)-activated lymphocytes and/or HIV-1 recombinant proteins significantly decreased or removed the presence of these HIV-1-immunoreactive antibodies. Together, these findings suggest that the immune response to a natural measles virus infection results in the production of antibodies to HIV-1 and possibly autoantigens.

Keywords: HIV-1; measles; indeterminate Western blot

Document Type: Original article

DOI: 10.1046/j.1365-2249.1998.00488.x

Affiliations: 1: Laboratory of Immunology, National Institute on Aging, NIH, 2: Maryland State Health Department, Baltimore, MD, 3: Howard University School of Medicine, Washington, DC, 4: Case Western Reserve University School of Medicine, Cleveland OH, 5: Merck Research Laboratories, West Point, PA, USA

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on InterScience.

You may be required to register and activate access on InterScience before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A